Anavex Life Sciences Corp (AVXL)

[WolfofMia]

I don't believe the FDA would proactively reach out to Anavex, or any company, with advice to change the primary endpoint and upgrade the trial from P2 to P3.

I was thinking the same, and I believe what it was meant to be said is that the discussion was had with the FDA.

Now since the FDA is not the approving body of these changes, since the trials are not in the USA, then they dont need to approve officially like UK and Australia do.

They could have acknowledge the change in any of their meetings.

Either way, we are good in that front as we changed the endpoint to a harder to meet one based on research and guidance that came out on the old one.

Still trying to understand how this is negative lol.

I mean I understand the spin reason, but not how serious investors would believe it.